Ever wondered what a doctor who specializes in obesity medicine eats? We asked one to share their day of eating with us.
U
Read full storyUsa Today
Original source
usa today
Check live status on DownRightNow
Trending
Meta Failed to Catch Hundreds of AI Child Abuse Ads. Some Included Images of Real KidsSouth Florida’s top deals: Ares buys two Miami warehouses for $108MSenate 'pure toss-up' ahead of midterms: DDHQJal Jeevan Mission: 50 pc households face water shortfall in TN, says CAG reportRoad crash on KMP expressway leaves three dead in HaryanaWant to borrow a dinosaur fossil? Try California’s one-of-aMan finds dirt, insects in Rs 60 mango fruit drink, Rs 20,000 payout orderedWhy bother deseeding tomatoes? | Kitchen aideMeta Failed to Catch Hundreds of AI Child Abuse Ads. Some Included Images of Real KidsSouth Florida’s top deals: Ares buys two Miami warehouses for $108MSenate 'pure toss-up' ahead of midterms: DDHQJal Jeevan Mission: 50 pc households face water shortfall in TN, says CAG reportRoad crash on KMP expressway leaves three dead in HaryanaWant to borrow a dinosaur fossil? Try California’s one-of-aMan finds dirt, insects in Rs 60 mango fruit drink, Rs 20,000 payout orderedWhy bother deseeding tomatoes? | Kitchen aide
Check status →
Related Stories
Health1h ago
AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group
REDWOOD CITY, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- AirNexis Therapeutics, Inc. ("AirNexis"), a clinical-stage biotech company developing therapeutics for pulmonary diseases, today announced results from a Phase 2b study of AN01, a dual PDE3/4 inhibitor DPI. The study, HSK39004-T1-202, was conducted in China by AirNexis' partner Haisco Pharmaceutical Group ("Haisco"). The Phase 2b study enrolled patients with chronic obstructive pulmonary disease (COPD) receiving background therapy of single or dual bronchodilator maintenance therapy who remained symptomatic despite such treatment. Data were presented earlier today at the 2026 European Respiratory Society (ERS) Congress in Barcelona, Spain. The ePoster will be available on the conference's website. AirNexis licensed AN01 (HSK39004 in China) from Haisco, which is developing the asset for the Greater China market; AirNexis holds development rights outside China.
GGlobe Newswire
Health1h ago
Australian pollen season may be arriving early in eastern states
Australian pollen season may be arriving early in eastern states Medical Xpress Has hay fever season started early? And what’s the most common culprit? The Conversation What you need to know about seasonal illnesses this spring SBS Expat reveals health condition that's much worse in Australia: 'Every night at 4am' au.news.yahoo.com
GGoogle News
Brief
Health7h ago
I’m a doctor — here’s how to check your blood pressure at home
Dr Pauline Swift explains how to take an accurate reading.
EExpress
Health7h ago
Eljamel: Public evidence hearings begin into rogue surgeon
Sam Eljamel was a consultant neurosurgeon at Ninewells Hospital from 1995 until his suspension in 2013.
TThe Bbc